Corporate Update – FLSmidth & Co. A/S

FLSmidth & Co. A/S (FLS.CO) closed the trading session on Tuesday, 20 October 2026, down 1.61 % at 10:47 PM Central Europe. The share price was approximately DKK 575, with a current trading volume of about DKK 41.5 million. The company’s market capitalization stands at DKK 30.8 billion, and the total shares outstanding amount to 53.1 million. Over the last 24 hours, the total value of shares traded was DKK 41.5 million, while the simple moving average over the preceding 200 trading days is DKK 521.61. The 52‑week high reached DKK 619.5 on 12 February 2026, and the 52‑week low was DKK 387.6 on 18 November 2025.

Leadership and Strategic Direction

On 1 November 2026, FLSmidth announced the appointment of Gonzalo Del Carpio as Chief Operational Excellence Officer. This change is part of a broader strategy to accelerate organic growth, pursue strategic acquisitions, and reinforce the company’s digital and technology capabilities, with a particular emphasis on artificial intelligence integration.

Analyst Outlook

Two Danish banking institutions have revised their target prices for FLSmidth shares upward, setting new targets at approximately DKK 660 and DKK 635 respectively. Both analysts maintain a neutral “hold” recommendation, indicating confidence in the company’s medium‑term prospects while acknowledging current market volatility.

Share Buy‑Back Activity

During the week preceding the announcement, FLSmidth executed several share buy‑back transactions under its existing programme, adding roughly 1.3 million shares to its treasury holdings. This activity reflects the company’s commitment to shareholder value and aligns with its broader capital management strategy.


CompanyTicker% ChangeCurrent Price (DKK)Market Cap (DKK bn)P/EKey Corporate Events
Zealand Pharma A/SZEAL.CO–1.99 %229.815.15.75Phase 1 safety data for ZP9830; Phase 1b plans
Gn Store Nord A/SGN.CO–0.28 %106.815.485.54High short‑interest activity
Royal UnibrewRBREW.CO+0.61 %43720.413.1Share‑buyback programme (mid‑Aug – mid‑Dec)
Alm Brand A/SALMB.CO+0.23 %17.2923.429.32Share‑buyback programme (May 2026)
Ambu A/SAMBU‑B.CO–4.15 %76.919.940.01–

Zealand Pharma A/S

Zealand Pharma reported encouraging safety results for its novel Kv1.3 ion‑channel blocker, ZP9830, from a Phase 1 trial involving 32 healthy volunteers over four weeks. The compound was well tolerated, with no serious or dose‑limiting adverse events. Pharmacokinetic data support progression to a Phase 1b trial in plaque psoriasis, with plans to expand into other autoimmune indications by the first half of 2027.

Gn Store Nord A/S

Gn Store Nord remains among the Danish companies with notable short‑position activity, reflecting investor caution regarding its near‑term prospects. No new corporate actions or earnings updates were disclosed.

Royal Unibrew

Royal Unibrew’s shares gained modestly early in trading, contributing to a slight rebound in the C25 index. The company’s share‑buyback programme, running from mid‑August to mid‑December, has a total purchase cap of approximately DKK 300 million. About 400,000 shares have already been repurchased, representing roughly 4 % of the company’s capital.

Alm Brand A/S

Alm Brand’s share‑buyback programme, launched in May 2026 with a commitment of up to DKK 593 million, has repurchased approximately 1.5 million shares between 13 and 19 October. The programme has increased the company’s treasury holdings to about 3.6 % of the outstanding float.

Ambu A/S

Ambu’s shares fell 4.15 % to DKK 76.9. No additional corporate updates were reported.


Company Profile – FLSmidth & Co. A/S

FLSmidth & Co. A/S is headquartered in Valby, Denmark, and specializes in the design, manufacture, and supply of production plants, equipment, machinery, and spare parts for the cement and minerals industries. The company operates globally, serving a diverse customer base across multiple regions. FLSmidth is listed on the OMX Nordic Exchange Copenhagen AS. For more information, visit www.flsmidth.com .